Literature DB >> 23958782

Graphene and graphene oxide as new nanocarriers for drug delivery applications.

Jingquan Liu1, Liang Cui, Dusan Losic.   

Abstract

The biomedical applications of graphene-based materials, including drug delivery, have grown rapidly in the past few years. Graphene and graphene oxide have been extensively explored as some of the most promising biomaterials for biomedical applications due to their unique properties: two-dimensional planar structure, large surface area, chemical and mechanical stability, superb conductivity and good biocompatibility. These properties result in promising applications for the design of advanced drug delivery systems and delivery of a broad range of therapeutics. In this review we present an overview of recent advances in this field of research. We briefly describe current methods for the surface modification of graphene-based nanocarriers, their biocompatibility and toxicity, followed by a summary of the most appealing examples demonstrated for the delivery of anti-cancer drugs and genes. Additionally, new drug delivery concepts based on controlling mechanisms, including targeting and stimulation with pH, chemical interactions, thermal, photo- and magnetic induction, are discussed. Finally the review is summarized, with a brief conclusion of future prospects and challenges in this field. Crown
Copyright © 2013. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Drug delivery; Graphene; Graphene oxide; Nano-carriers; Targeted drug delivery

Mesh:

Substances:

Year:  2013        PMID: 23958782     DOI: 10.1016/j.actbio.2013.08.016

Source DB:  PubMed          Journal:  Acta Biomater        ISSN: 1742-7061            Impact factor:   8.947


  130 in total

1.  Graphene oxide inhibits hIAPP amyloid fibrillation and toxicity in insulin-producing NIT-1 cells.

Authors:  Praveen Nedumpully-Govindan; Esteban N Gurzov; Pengyu Chen; Emily H Pilkington; William J Stanley; Sara A Litwak; Thomas P Davis; Pu Chun Ke; Feng Ding
Journal:  Phys Chem Chem Phys       Date:  2015-12-02       Impact factor: 3.676

2.  Toxicity of different forms of graphene in a chicken embryo model.

Authors:  Maciej Szmidt; Ewa Sawosz; Kaja Urbańska; Sławomir Jaworski; Marta Kutwin; Anna Hotowy; Mateusz Wierzbicki; Marta Grodzik; Ludwika Lipińska; André Chwalibog
Journal:  Environ Sci Pollut Res Int       Date:  2016-07-19       Impact factor: 4.223

Review 3.  Multifunctionalization of graphene and graphene oxide for controlled release and targeted delivery of anticancer drugs.

Authors:  Cui-Cui Liu; Jing-Jing Zhao; Rui Zhang; Hui Li; Bo Chen; Ling-Ling Zhang; Hao Yang
Journal:  Am J Transl Res       Date:  2017-12-15       Impact factor: 4.060

4.  Heparin-dopamine functionalized graphene foam for sustained release of bone morphogenetic protein-2.

Authors:  Qingqing Yao; Yangxi Liu; Hongli Sun
Journal:  J Tissue Eng Regen Med       Date:  2018-05-18       Impact factor: 3.963

Review 5.  Brain Theranostics and Radiotheranostics: Exosomes and Graphenes In Vivo as Novel Brain Theranostics.

Authors:  Minseok Suh; Dong Soo Lee
Journal:  Nucl Med Mol Imaging       Date:  2018-11-09

6.  In vivo compatibility of graphene oxide with differing oxidation states.

Authors:  Stefanie A Sydlik; Siddharth Jhunjhunwala; Matthew J Webber; Daniel G Anderson; Robert Langer
Journal:  ACS Nano       Date:  2015-04-10       Impact factor: 15.881

7.  Nanomaterial based drug delivery systems for the treatment of neurodegenerative diseases.

Authors:  Shima Masoudi Asil; Jyoti Ahlawat; Gileydis Guillama Barroso; Mahesh Narayan
Journal:  Biomater Sci       Date:  2020-07-08       Impact factor: 6.843

8.  Electrophoretic deposition of graphene oxide reinforced chitosan-hydroxyapatite nanocomposite coatings on Ti substrate.

Authors:  Y Y Shi; M Li; Q Liu; Z J Jia; X C Xu; Y Cheng; Y F Zheng
Journal:  J Mater Sci Mater Med       Date:  2016-01-12       Impact factor: 3.896

9.  Systematic toxicity investigation of graphene oxide: evaluation of assay selection, cell type, exposure period and flake size.

Authors:  V Gies; S Zou
Journal:  Toxicol Res (Camb)       Date:  2017-12-04       Impact factor: 3.524

Review 10.  Lipoproteins and lipoprotein mimetics for imaging and drug delivery.

Authors:  C Shad Thaxton; Jonathan S Rink; Pratap C Naha; David P Cormode
Journal:  Adv Drug Deliv Rev       Date:  2016-04-29       Impact factor: 15.470

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.